Pavlovian cues for rewards can become attractive incentives: approached and 'wanted' as the rewards themselves. The motivational attractiveness of a previously learned cue is not fixed, but can be dynamically amplified during re-encounter by simultaneous activation of brain limbic circuitry. Here it was reported that opioid or dopamine microinjections in the dorsolateral quadrant of the neostriatum (DLS) of rats selectively amplify attraction toward a previously learned Pavlovian cue in an individualized fashion, at the expense of a competing cue. In an autoshaping (sign-tracking vs. goal-tracking) paradigm, microinjection of the mu opioid receptor agonist (DAMGO) or dopamine indirect agonist (amphetamine) in the DLS of sign-tracker individuals selectively enhanced their sign-tracking attraction toward the reward-predictive lever cue. By contrast, DAMGO or amphetamine in the DLS of goal-trackers selectively enhanced prepotent attraction toward the reward-proximal cue of sucrose dish. Amphetamine also enhanced goal-tracking in some sign-tracker individuals (if they ever defected to the dish even once). That DLS enhancement of cue attraction was due to stronger motivation, not stronger habits, was suggested by: (i) sign-trackers flexibly followed their cue to a new location when the lever was suddenly moved after DLS DAMGO microinjection; and (ii) DAMGO in the DLS also made sign-trackers work harder on a new instrumental nose-poke response required to earn presentations of their Pavlovian lever cue (instrumental conditioned reinforcement). Altogether, the current results suggest that DLS circuitry can enhance the incentive salience of a Pavlovian reward cue, selectively making that cue a stronger motivational magnet.
Introduction
The neostriatum is traditionally considered a motor structure, and the dorsolateral quadrant of the striatum (DLS) is viewed to mediate movement and habit functions (e.g. action sequencing and habit automaticity; Packard & Knowlton, 2002; Balleine et al., 2007; Tang et al., 2007; Yin, 2010; Bornstein & Daw, 2011; Everitt & Robbins, 2013; Smith & Graybiel, 2013; Kalueff et al., 2016) . However, the neostriatum also is increasingly recognized to have motivation-related functions, including potentially the DLS and other dorsal regions of the neostriatum (Palmiter, 2008; Wise, 2009; Kravitz et al., 2012) . For example, the dorsal neostriatum is activated by drug cues in human addicts (i.e. Pavlovian conditioned stimuli or CSs), and by food cues in obese and binge eaters (Volkow et al., 2002; Stice et al., 2008; Nummenmaa et al., 2012; Jastreboff et al., 2013) . Similarly in rats, DLS levels of enkephalin surge when palatable food is encountered, and opioid stimulation in the DLS causes increases in eating behaviour . Further, DLS lesions in rats disrupt the ability of Pavlovian cues to trigger peaks of increased effort to obtain reward in Pavlovian-instrumental transfer (PIT) studies (Corbit & Janak, 2007) , potentially indicating a need for DLS in cuetriggered incentive salience or 'wanting' for reward.
The intensity of incentive salience triggered by a Pavlovian reward cue can be amplified by relevant physiological appetites and by localized neurobiological stimulations of limbic circuitry (Robinson & Berridge, 1993 Mahler & Berridge, 2009; Hickey & van Zoest, 2012) . For example, dopamine and opioid stimulations in limbic structures, such as the nucleus accumbens or central amygdala, are especially effective at amplifying the incentive salience of a previously-learned Pavlovian reward cue (Wyvell & Berridge, 2001; Smith et al., 2011; Mahler & Berridge, 2012; Pecina & Berridge, 2013; Robinson et al., 2014a) .
Incentive salience can make a Pavlovian cue become attractive and 'wanted'. Amplification of incentive salience raises a cue's attractiveness, making it into a stronger 'motivational magnet' that elicits approach and even consummatory behaviours. In animal studies, this can be studied via the Pavlovian autoshaping paradigm, which reveals individual differences in attraction toward reward cues as either sign-tracking or goal-tracking responses Robinson et al., 2014b) . For example, insertion of a metal lever into a chamber's wall serves as a Pavlovian CS+, or reward-correlated sign that predicts delivery of a sucrose pellet into a dish as unconditioned stimulus (UCS; Zener, 1937; Jenkins & Moore, 1973; Boakes et al., 1978; Flagel et al., 2009; Meyer et al., 2012) . After learning the CS-UCS association, some individual rats (called sign-trackers) approach the CS+ and avidly sniff and nibble the lever cue. By contrast, other individuals (called goal-trackers) respond to CS+ insertion by instead approaching and nibbling the reward-contiguous dish where sucrose is actually received.
Here it is tested whether the DLS has the capacity to amplify the incentive salience of a particular reward cue in an individually tailored fashion, when neurochemically activated by either local opioid stimulation (via DAMGO microinjection) or local dopamine stimulation (via amphetamine microinjection).
Materials and methods

Overview
The effect of DAMGO vs. amphetamine microinjections was compared in the DLS, or alternatively in the dorsomedial neostriatum (DMS), on CS+ incentive salience. Incentive salience of Pavlovian cues was assessed by measuring changes in sign-tracking vs. goaltracking behaviours after rats had learned the CS-UCS association. Lever cue presentation (CS+Lever), which predicts sucrose, is a CS+ 'trigger' potentially able to elevate incentive salience, especially when limbic circuitry is simultaneously pharmacologically stimulated (Berridge, 2012) . Sign-trackers and goal-trackers differ in their target of incentive salience (Robinson et al., 2014b) . For signtrackers, the CS+Lever becomes the target of motivation as well as the trigger, so that sign-trackers approach, sniff and nibble the predictive lever cue. By contrast, for goal-trackers, especially in states of mesocorticolimbic pharmacological stimulation, the more 'wanted' target becomes the goal dish (CS dish) where sucrose UCS is obtained, even though the temporal trigger for the phasic surge in target attraction remains the CS+Lever (Mahler & Berridge, 2009; .
It was assessed whether DLS stimulation amplified motivation vs. an automatic motor habit by asking if DLS enhancement of signtracking impeded flexible switching of CS+ approach to a new location, when the location of the target CS+Lever was suddenly changed (Carr & Watson, 1908) . It was further confirmed that DAMGO microinjection in the DLS indeed enhanced CS+ motivation, making the cue more 'wanted', by showing DLS opioid stimulation also increased instrumental conditioned reinforcement: sign-tracking rats acquired a new nose-poke response and performed it at higher levels to earn presentations of the CS+Lever.
In order to help map localization of function within the dorsal neostriatum, Fos plume maps of behavioural effects were constructed, following procedures described by previous studies (Pecina & Berridge, 2005; Richard & Berridge, 2011) . First, the diameter of drug impact on neuronal function was assessed by measuring local drug-induced elevation (relative to vehicle microinjections) in Fos protein expression in cells surrounding a drug microinjection 'Fos plume'. The mean size of measured Fos plume diameters was then used to set the size of function symbols in neostriatum maps. The site of each rat's microinjection was identified histologically after the experiments. Each rat's incentive salience effects of DAMGO, measured by changes in sign-tracking or goal-tracking behaviour produced by drug microinjections relative to its vehicle-control trial, were mapped onto its anatomical site using colour-coded symbols on brain atlas representations of the neostriatum (Paxinos & Watson, 2007) .
Details of methods
Subjects
Female Sprague-Dawley rats bred in-house, were between 4 and 5 months old, and between 280 and 350 g body weight at the start of the experiment (n = 81 total: n = 28 for sign-tracking/goal-tracking tests; n = 14 for moved-cue tests; n = 38 for instrumental conditioned reinforcement tests). Females were used in order to allow comparisons to data from previous articles from the authors' lab reporting enhancements in female rats of sign-tracking vs. goaltracking or by microinjections of DAMGO or amphetamine (e.g. in the amygdala; Mahler & Berridge, 2009; Robinson & Berridge, 2013; Robinson et al., 2014a Robinson et al., , 2015b . Pavlovian sign-tracking and goal-tracking responses remain stable across the oestrous cycle in females (Pitchers et al., 2015) . Another reason why females were used was to conform to recent NIH directives to not rely on male-only groups (Clayton & Collins, 2014 ). An explicit comparison across sexes would have required doubling the number of rats, and so was not included here but could be done by future studies. Rats were pair-housed on a reverse light/ dark cycle. Water was always provided ad libitum; food was also provided ad libitum except during autoshaping training or test weeks, when rats were restricted to 90% free-feeding weight (about 14 g of standard laboratory chow provided daily after each training session). Before surgery, all rats received 24 handling sessions of 10 min each to acclimate them to being held and moved to the laboratory. All experiments were conducted in accordance with protocols approved by the University of Michigan Committee on Use and Care of Animals (UCUCA).
Surgery
Rats were anaesthetized with ketamine (80 mg/kg), xylazine (7 mg/ kg) and atropine (0.04 mg/kg). To prevent infection, chloramphenicol sodium succinate (60 mg/kg) was administered, and carprofen given immediately after surgery (5 mg/kg) as an analgesic. Carprofen and chloramphenicol doses were repeated again 24 h later. Rats were allowed 5-7 days to recover from surgery before any training or testing began.
Chronic bilateral 14 mm (23-gauge) guide cannulae were implanted aimed at sites in the DLS (individually staggered sites between AP +0 and 2.5, ML AE3.0 and 4.0, DV À3.5 and À4.5, all relative to bregma with the head secured in flat skull position), or alternatively at control sites in the DMS as an anatomical comparison (between AP +0 and 2.5, ML AE1.8, and DV À3.5 and À4.5; Paxinos & Watson, 2007) . Guide cannulae tips were aimed 2 mm above intended target injection sites, because the actual microinjectors for drugs extended a further 2 mm below guide cannulae into the intended site. Guide cannulae were anchored to the skull with bone screws and acrylic cement. Steel stylets were inserted into guide cannulae to prevent occlusion, and removed only prior to microinjections. Anatomical sites were confirmed histologically after each experiment.
Microinjections and drugs
Prior to all behavioural tests, stylets were removed and guide cannulae were cleaned, before 16 mm microinjectors were inserted into the guide cannulae. Microinjections of , N-MePhe 4 , Gly-ol]-enkephalin (DAMGO; Sigma; 973 lM concentration at 0.25 lg/ 0.5 lL dose), amphetamine (116.5 mM concentration at 10 lg/ 0.5 lL dose) or vehicle alone (artificial cerebrospinal fluid; Harvard Apparatus) were controlled by a syringe pump that delivered 0.5 lL over a 2-min period. Microinjection cannulae were left in place for an additional 1 min following the microinjection to allow drug diffusion. Each rat also received a 'sham' microinjection of vehicle on the day prior to the first test to habituate to the procedure.
Behavioural autoshaping training
Autoshaping training procedures were the same as in the authors' previous studies (Mahler & Berridge, 2009; . In brief, autoshaping training and testing was always carried out in the same operant chamber for a particular rat, containing two retractable levers on opposite sides of a food receptacle (Med Associates), controlled by Med PC software. Rats first received a session of magazine training consisting of 20 sucrose pellets being delivered into the food dish. Pavlovian autoshaping training (CS+ paired with UCS) began the second day. Training sessions began with illumination of the red house light. Each UCS presentation was preceded by insertion of the CS+Le-ver, which carried a light-emitting diode on its ventral surface and was accompanied by an auditory 2.9 kHz tone. The CS+Lever/tone presentation lasted 8 s, after which the lever was retracted back through the wall, and was immediately followed by delivery of one sucrose pellet into the goal dish (UCS; Test Diet). Twenty-five CS+ UCS pairs were presented on a 90 s variable inter-trial interval schedule during the 40-min session. A control lever was always present in the chamber. A camera was positioned under the transparent floor of the autoshaping chamber to provide a clear view of the rat's entire head and body wherever it was in the chamber, and allowed visual scoring of approaches to the lever or dish, as well as scoring of consummatory sniffing, licking and biting of the lever. A second camera was directed from the side toward the inner surface of the CS dish to allow scoring of consummatory sniffing, nibbles or biting of the dish. Video-recorded behaviours were scored later offline by the experimenter blind to the drug condition. Lever depressions and beam-break entries into the dish were also recorded automatically.
Training sessions were repeated over five consecutive days. By the 3rd training day, every rat began to respond to the CS+ onset with an approach-consummatory conditioned response predominantly focused toward either the CS+Lever or the CS dish . The criterion for classification as a predominant sign-tracker was to approach, nibble, sniff, grasp and bite the CS+Lever at least three times more frequently than they did the sucrose dish during CS+ presentations on day 5. The criterion for classification as predominant goal-tracker was: (i) to approach, nibble, sniff, grasp and bite the dish at least three times more frequently than the lever during CS+ presentations; and additionally (ii) to approach the CS dish three times more frequently when the CS+Lever was present than in intervening baseline periods when the CS+ was absent (to ensure that CS+Lever presentation was the trigger for a phasic elevation in goal-tracking behaviour, as the dish was present during baseline periods as well as during CS+ and UCS presentations). All rats' phenotypes were discernible by day 3.
Autoshaping testing
After a sham microinjection on day 6, behavioural testing was conducted on days 7 and 9. Each rat received either a DAMGO or vehicle microinjection immediately prior to the autoshaping test on day 7 (n = 13), and received the other microinjection on the repeated test on day 9 (order counterbalanced across rats) following a day of rest. A separate group of identically trained rats (n = 15) similarly received either an amphetamine microinjection or vehicle microinjection in counterbalanced order. After microinjections, rats were immediately placed in their usual autoshaping chamber. Each test consisted of 25 CS-UCS presentations identical to training.
Behavioural video scoring: autoshaping
Videos from the two cameras were analysed off-line in slow motion (1/10th to ½ actual speeds) by an observer blind to experimental conditions. For each trial, the 8 s before and 8 s during the 5th, 10th, 15th, 20th and 25th presentation of the CS+ were selected for comparison (Mahler & Berridge, 2009 ). Appetitive behaviours scored were: 'look' at the cue (orienting towards the cue by moving the head or forequarters toward it, without bodily approaching it); and 'approach' the cue to make contact or within 1 cm. Consummatory behaviours towards the CS+Lever or dish (similar to ingestive movements directed at UCS sucrose pellets) were scored: 'sniff' the cue (contact of the nose and rhythmic nose-flaring movements with either lever or dish); 'nibble' the cue [short contacts (< 0.5 s) of mouth or teeth on lever or dish, combined with rapid opening and closing movements of jaw and rhythmic 1-2 Hz bobbing movements of the head]; and slow 'bite' of the cue (jaw closing and contact by maxillary and mandibular incisors for > 0.5 s, often while grasping the cue lever or dish with one or both paws).
Free intake paradigm testing
To assess the effects of DAMGO microinjections into the DLS on food and water intake, rats received free access to palatable milk chocolate candies (M&Ms) in a 1-h intake test after receiving microinjections . DAMGO or vehicle administration was counterbalanced across days with 48 h between each testing session. Prior to any test, rats were habituated for 4 days to clear plastic tub cages with~3 cm of corn cob bedding, 20 g of pre-weighed M&Ms and 20 g of pre-weighed chow. Water was always available through a drinking spout. At the end of each intake test, any remaining M&Ms or chow were counted and re-weighed, and videoed eating behaviour was scored at a later date offline.
Ingestive intake videos were scored by experimenters blind to the experimental condition of each rat. Seconds spent engaging in the following behaviours were recorded: eating M&Ms (actual chewing and consumption); eating chow pellets (similar consumption behaviours); drinking from spout; and non-ingestive chewing on nonfood bedding, cage or spout. Also, sniffing M&Ms (anticipatory sniffs and approaches, without actual eating), sniffing chow, grooming, cage crossing and rearing were additionally recorded as single events each time they occurred (Richard & Berridge, 2011) .
Histology and Fos plume measurement
Rats were killed immediately after the final day of testing by a sodium pentobarbital overdose. Rats that had been behaviourally tested were decapitated, and the brains were extracted and fixed in 10% paraformaldehyde solution for 1-2 days followed by a 25% sucrose solution in 0.1 M NaPB for 2-3 days before slicing. Sixtymicron slices through the neostriatum were taken from each rat, mounted, dried and stained with Cresyl violet. The microinjection centre was determined for each bilateral injection site mapped onto a stereotaxic atlas (Paxinos & Watson, 2007) to locate placement within the DLS or DMS. Rats used for Fos analysis were anaesthetized and transcardially perfused 90 min after bilateral microinjection of vehicle (dorsomedial n = 8; dorsolateral n = 6), DAMGO (dorsomedial n = 10; dorsolateral n = 9), or normal (no injection, dorsomedial n = 2; dorsolateral n = 2). Brains were extracted, frozen and sliced at 40 lm. Brain slices were processed for Fos-like immunoreactivity using normal donkey serum, goat anti-c-fos (1 : 500; Santa Cruz Biotechnology) and donkey anti-goat Alexa Fluor 488 (excitation = 488 nm, emission = 519 nm; Invitrogen; Reynolds & Berridge, 2008) . Sections were mounted, air-dried and coverslipped with Prolong Gold antifade reagent (Invitrogen). The radius and intensity of plumes of c-Fos positive cells surrounding the microinjection 'Fos plumes' site were mapped as described previously (Pecina & Berridge, 2005; Richard & Berridge, 2011) .
Mapping localization of function via Fos plumes
Localization of function within the dorsal neostriatum was mapped by assigning behavioural effects produced at each identified site to its corresponding brain atlas location, using colour-coded symbols. The size of the symbols was based on the average maximum radius of 'Fos plumes' observed surrounding the site of DAMGO microinjections (elevation over vehicle-induced levels). Fos plumes were measured in separate rats after a single microinjection in order to capture maximal spread, and avoid plume shrinkage. That was because a series of repeated microinjections in behaviourally tested animals has been shown to diminish the size of Fos plume induced by a final drug microinjection (Richard & Berridge, 2011; Castro & Berridge, 2014) , and an underestimate of Fos plume size could give rise to overly-precise estimates of localization. All information beyond symbol size contained in maps was obtained from behaviourally tested rats (symbol sites and behavioural colour intensities).
Moved-cue experiment
The 'moved lever' experiment was assessed in separate rats (n = 14) after identical autoshaping training to ask whether DAMGO DLS stimulation amplified perseveration of a habitual motor ritual of approach movements toward the old CS+ location, or instead enhanced flexible attraction to the moved cue's new location. Rats were trained as above, receiving 5 days of 25 CS+ UCS pairings per day, and sign-trackers vs. goal-trackers were identified on the 5th day. A between-subjects design was used for testing on day 7, so that each rat could encounter the new location cue shift for the very first time under either DAMGO or vehicle. Sign-trackers arbitrarily received either DAMGO or vehicle microinjections in the DLS, and were immediately placed in the autoshaping chamber. On this day, the CS+Lever was inserted into the box in a new location, on the opposite wall from its accustomed location (Fig. 6B ). The old location was left empty on this day. Video-recorded approaches and movement sequences toward the old location vs. new location were scored. Additionally, a choreography of approach movements and trajectories was scored, both for the last two videotaped training days to the old location, and the test day with the new location to allow identification and comparison of any movement rituals. During the moved-cue test, responses to the first three presentations of the lever were selected for video analysis in order to capture initial reactions to the shift of CS+Lever to its novel location.
Instrumental conditioned reinforcement testing
Another way to assess whether DAMGO microinjection in the DLS enhances motivated 'wanting' for CS+ is to test for enhancement of instrumental conditioned reinforcement, which is the willingness to work more to obtain the cue by itself. After 5 days of autoshaping training, identified sign-trackers were microinjected on the test day with either DAMGO or vehicle in DLS, immediately before being placed in an operant chamber for a test of instrumental conditioned reinforcement. In this test, the operant chamber contained two novel nose-poke ports, located on either side of a retractable lever port (the lever was kept retracted until earned by nose-pokes in the designated port hole; Fig. 7 ). One nose port was randomly assigned as 'active', so that pokes into it produced the CS+Lever (FR1). The other port was inactive, serving merely as a control stimulus option for exploratory responses, and pokes in it were recorded but produced no consequence. Each poke into the active nose port resulted in a 2-s presentation of the Pavlovian CS+Lever and its associated tone (no sucrose was ever delivered, and the previous dish was absent from the chamber). Each conditioned reinforcement session lasted 30 min.
Statistical analysis
Within-subject repeated-measures analyses of variance (ANOVA) compared drug and vehicle, while anatomical site placement within dorsolateral vs. dorsomedial regions of the neostriatum, and signtracker vs. goal-tracker phenotype were between-subjects variables. Between-subject multivariate and univariate ANOVAs were used to assess the moved cue and conditioned reinforcement tests. All post hoc t-tests presented were corrected for multiple comparisons using the Bonferroni correction. Measures of effect size, where appropriate, were presented as partial eta squared and Cohen's d.
Results
Sign-trackers vs. goal-trackers
Sign-trackers were identified as individuals that approached the CS+Lever and nibbled it at least > 3 times more than they approached the dish on day 3, during the 8-s lever presentations (Meyer et al., 2012) . Two types of sign-trackers were distinguished. Several DLS sign-tracker individuals did not approach the dish even once while the CS+Lever was present on vehicle microinjection test trials, and therefore were considered to be 'exclusive' sign-trackers. Other sign-trackers went reliably to the CS+Lever as soon as it appeared, but occasionally defected to the dish while the CS+Lever was still extended: typically these rats went first to the lever, and then went to the dish before the lever was retracted (whereas exclusive sign-trackers waited until the lever was retracted before moving to the dish to obtain sucrose). Conversely, goal-trackers were identified as individuals that approached, sniffed and nibbled the 'goal' or metal dish where sucrose pellets were delivered (CS dish ) > 3 times more than lever, when CS+Lever was present on day 3, and continued to increase goal-tracking over subsequent training days. Finally, rats were classified as intermediate or mixed if they failed to prefer either cue by > 3 times than the other cue, and so showed nearly equal numbers of conditioned approaches to both CS+Lever and CS dish while the lever was extended.
DAMGO in the DLS enhances attraction to a prepotent cue
Bilateral microinjections of DAMGO in the DLS (0.25 lg/0.5 lL) made all rats become even more intensely attracted to their prepotent cue (CS+Lever for sign-trackers; CS dish for goal-trackers; Figs 1 A and 2) All rats approached their prepotent cue faster after DAMGO microinjections in the DLS than after vehicle microinjections (omnibus: F 2,12 = 17.87, P < 0.001, gp 2 = 0.764; latency: F 1,12 = 6.84, P = 0.023, gp 2 = 0.363; Fig. 1A ). Once the lever or dish was reached, DAMGO made each rat also display nearly twice as many sniff, grasp and nibble consummatory acts to their prepotent metal CS+ than on control vehicle trials (F 1,12 = 22.3, P < 0.001, gp 2 = 0.651; Fig. 1A ). Split by phenotype, for signtrackers, DAMGO microinjection in the DLS selectively sped up the approach to the CS+Lever compared with vehicle-control trials in the same rats (omnibus F 2,3 = 4.972, P = 0.12, gp 2 = 0.768; F 1,4 = 2.4, P = 0.19, gp 2 = 0.375; Fig. 1B ), without changing approach to the CS dish cue. Once the lever was reached, DAMGO also made sign-trackers emit more consummatory sniffs and nibbles toward the metal lever than on vehicle control trials (F 1,4 = 12.9, P = 0.023, gp 2 = 0.764; Figs 1B and 2). For goal-trackers, DAMGO microinjections in the DLS instead did not change approaches toward the CS+Lever, but instead marginally sped up (decreased latency) goal-trackers' approach to the CS dish (omnibus F 2,6 = 19.37, P = 0.002, gp 2 = 0.866; latency: F 1,7 = 4.64, P = 0.07, gp 2 = 0.389; Fig. 1C) , and increased the number of consummatory sniffs and nibbles on the dish by about 20% over vehicle control levels (F 1,7 = 16.047, P = 0.005, gp 2 = 0.696; Figs 1C and 2). By comparison, DAMGO in the DLS never enhanced consummatory actions toward the alternative non-preferred cue for any rat (all actions towards non-preferred cue: t 12 = 0.989, P > 0.05). Therefore, whichever CS object was already prepotent for an individual rat, opioid stimulation in the DLS made that particular prepotent CS become more attractive and more able to elicit ingestivestyle nibbles and sniffs.
CS+ as temporal trigger
The temporal pattern of DLS opioid enhancement of cue attraction was always time-locked to the presentations of the CS+Lever, regardless of phenotype: approach was triggered by the lever's appearance through the wall, continued for as long as the lever was present, and declined when it was retracted (Fig. 1) . Even for goaltrackers, whose CS dish was always physically available, the DAMGO-enhanced peaks in CS dish approach were phasically bound to the presence of CS+Lever, and faded almost immediately after the lever disappeared (Fig. 1C) . It has previously been suggested that such temporal patterns reveal the distinction between a CS as a 'trigger' vs. as a 'target' for incentive salience attributions under limbic states of pharmacological stimulation . That is, the reward-predictive CS+Lever was always the temporal 'trigger' of enhanced incentive salience pulses for all rats, sign-trackers and goal-trackers alike. The same CS+Le-ver was also the 'target' attributed with incentive salience for signtrackers, which became their stronger motivational magnet. However, for goal-trackers, their target CS was the reward-proximal CS dish , which became the enhanced motivational magnet, and phasically more 'wanted' for goal-trackers during moments of triggering CS+Lever presence. Further supporting this trigger vs. target interpretation, even goal-tracker rats under DLS DAMGO never nibbled and sniffed their preferred goal dish more during inter-stimulus intervals when the lever was absent (t 11 = 0.072, P > 0.5).
Directional selectivity of DLS enhanced approach
A different aspect of the 'motivational magnet' strength of a CS attributed with incentive salience is its ability to reduce attraction to other competing CSs, narrowing the focus of 'wanting' to itself (Mahler & Berridge, 2009; . DAMGO microinjections in the DLS enhanced this motivational magnet focus for each rat's prepotent cue (CS+Lever or CS dish ): DAMGO in the DLS cut in half attraction to the alternative cue (12% vehicle to 6% DAMGO; t 12 = 6.85, P = 0.024, Cohen's d = 3.95; cue approach probability calculated according to Meyer et al., 2011 ; rats displayed individually in Fig. 2 ), while at the same time enhancing approach to the individual's prepotent cue as described above.
Sites in DMS failed to enhance CS attraction
By contrast to the DLS, sites in the DMS for DAMGO microinjections never altered cue approach probability for either sign-trackers or goal-trackers, and did not intensify prepotent attraction or did it shift rats between the two cues (vehicle = 98.46, DAMGO = 95.38; F 3,10 = 2.34, P > 0.1, n.s.). Similarly, DAMGO at DMS sites failed to alter approach speed, or latency to reach the preferred CS+Lever or CS dish for either group of rats (latency, vehicle = 1.2, DAMGO = 1.5, n.s.). Finally, DAMGO microinjections at sites in the DMS failed to alter the number of consummatory nibbles and sniffs in sign-trackers (CS+Lever) or goal-trackers (CS dish ) once a rat reached it's prepotent cue (vehicle = 6.0, DAMGO = 5.9, n.s.). Consequently, DLS sites differed from DMS sites for CS+ enhancement effects as an anatomical determinant (Drug*Placement: F 2,22 = 4.85, P = 0.010, gp 2 = 0.397). DMS sites failed to enhance cue attraction to Pavlovian CSs associated with sucrose reward, despite the previous finding that DAMGO microinjections in the DMS potently stimulate eating and intake of unconditioned sweet food itself .
Unconditioned food intake was not changed by DAMGO in DLS
Finally, DAMGO microinjections in the DLS failed to increase the amount of food eaten in the 1-h free intake test. Under vehicle conditions rats ate 8.25 g of M&Ms, and ate 8.48 g after DAMGO microinjection (t 12 = 0.223, P > 0.5). The lack of enhancement was likely not due to a ceiling effect, as large increases in eating behaviour and consumption to over 15 g of M&Ms after DAMGO in the anteromedial dorsal neostriatum (anterior DMS) from similar 8 g baselines have been previously observed . DAMGO microinjection in the DLS also did not alter any other behavioural measure collected during the free intake test. Rears (vehicle = 127.1, DAMGO = 110.9), cage crosses (vehicle = 59.3, DAMGO = 63.1) and grooming events (vehicle = 7.4, DAMGO = 7.2) did not increase after DAMGO injections (F 3,7 = 1.12, P = 0.402). A few rats' videos were corrupted and unscorable (n = 3), resulting in the slightly lower number reported for these measures.
Amphetamine in DLS shifted goal-trackers and sign-trackers toward goal bias (except exclusive sign-trackers)
Amphetamine microinjections in the DLS (10 lg/0.5 lL) selectively potentiated goal-tracking responses in most rats, both in all goaltrackers and also even in any predominant sign-trackers that had made a single goal-tracking approach to the CS dish while the CS+Lever still remained extended, as is typical of many sign-trackers (omnibus F 2,8 = 5.273, P = 0.03, gp 2 = 0.569; Fig. 3 ). These rats were called 'non-exclusive sign-trackers' (six of 10 predominant sign-trackers) to distinguish them from 'exclusive sign-trackers' that always remained focused on the CS+Lever throughout its entire 8-s
Nibbles and sniffs on prepotent cue presentations, and never defected at all to the dish while the still lever remained present (four of 10 predominant sign-trackers). For both goal-trackers and non-exclusive sign-trackers ( Fig. 3A and B) , amphetamine microinjection in the DLS sped up the approach specifically to the goal CS dish by 30% (latency to reach dish after amphetamine = 3.1 s, vehicle = 4.5 s; F 1,9 = 7.83, P = 0.048, gp 2 = 0.367), while simultaneously also slowing the first approach to the alternative CS+Lever for non-exclusive sign-trackers (latency amphetamine = 2.6 s, vehicle = 2.0 s; P > 0.05). Once the goal dish was reached by goal-tracker and non-exclusive sign-tracker rats, DLS microinjection of amphetamine also doubled the number of consummatory grasps, sniffs and nibbles directed toward the metal dish (though sucrose UCS was not yet delivered during the 8-s CS+Lever presentation; F 1,9 = 5.4, P = 0.011, gp 2 = 0.528). However, amphetamine in the DLS never actually reduced the probability of non-exclusive sign-trackers eventual approach to their CS+Lever (although it did slow their approach): the probability of sign-tracking still remained at 100% in all predominant sign-trackers after amphetamine (Fig. 4) . Thus, goal-tracking in non-exclusive sign-trackers was enhanced in a non-competitive fashion by DLS dopamine stimulation, facilitating the CS dish approach while slowing the approach to CS+Lever, but never actually pulling all triggered behaviour toward the CS dish at the expense of the CS+Lever.
By contrast, in 'exclusive sign-trackers' (four of 10 sign-trackers), amphetamine microinjection in the DLS did not enhance goal-tracking responses at all. Instead, amphetamine in the DLS of exclusive sign-trackers slightly enhanced sign-tracking: increasing by about 10% approaches to the CS+Lever, and similarly increasing nibbles, sniffs and bites (vehicle = 8.65, amphetamine = 9.65, F 1,3 = 8.13, P = 0.065, gp 2 = 0.730; Fig. 3C ). These exclusive sign-trackers never approached the CS dish while the CS+Lever remained physically present after DLS amphetamine microinjections, just as after vehicle microinjections. In other words, for exclusive sign-trackers, the effect of DLS amphetamine appeared similar to that of DLS DAMGO: both neurochemical forms of DLS stimulation selectively enhanced their prepotent (exclusively prepotent for these rats) response of sign-tracking. In sum, dopamine stimulation of the DLS selectively enhanced attraction toward a single CS+ in an individualized fashion (Fig. 4) . The CS+Lever became a stronger motivational magnet for exclusive sign-trackers, but the CS dish became a stronger motivational magnet for goal-trackers (again similar to DLS DAMGO) and for non-exclusive sign-trackers (a CS switching effect different from DLS DAMGO, which had potentiated prepotent signtracking responses in all sign-trackers, whether exclusive or nonexclusive).
Mapping localization of CS enhancement in DLS
Anatomical analysis of sites revealed that only the lateral half of the dorsal neostriatum (DLS) contained sites that produced enhancements of cue attraction after DAMGO or amphetamine microinjections as described above (Fig. 5) .
For mapping of behavioural effects, a microinjection site was classified to be within DLS if > 75% of its total Fos plume volume was estimated to be contained inside the lateral half of the dorsal neostriatum (Fig. 5) . In the DLS, DAMGO microinjections produced Fos plumes of similar intensity and size, about 0.2 mm in radius. DAMGO Fos plumes each contained a small centre of intense 200-400% Fos protein elevation (compared with vehicle microinjections as baseline; 0.13 mm radius, volume = 0.009 mm 3 ), and a larger surrounding sphere of moderate 150-199% elevation above normal Fos levels (0.2 mm radius, 0.033 mm 3 volume). These Fos plume sizes were used to make maps in Fig. 5 , and were similar to those previously reported for DAMGO microinjections in the DMS and nucleus accumbens at the same doses (Pecina & Berridge, 2005; Castro & Berridge, 2014) .
The most effective sites were clustered in the DLS (Fig. 5 ). For example, individual enhancements by DAMGO in the DLS often doubled or nearly tripled a rat's approaches to its prepotent cue, and likewise doubled consummatory nibbles directed toward the metal lever or dish. Effective sites filled most of the anterior-posterior extent of the DLS, stretching from the far rostral tip of the DLS (approximately +2.5 mm anterior to bregma) to at least two-thirds through the posterior extent of the DLS to at least 0 bregma, as far posterior as the sites reached in this study. Dorsoventrally, motivationally enhancing DLS sites extended from the dorsal surface of the lateral neostriatum to at least 1 mm below the surface (more ventrally at very lateral placements, though that is partly because the dorsal surface of the neostriatum also curves ventrally as it moves laterally). Beyond that ventral point, deeper sites were generally silent in motivational effects or, if anything, slightly suppressive (respectively, white or grey circles in Fig. 5 ). However, mediolaterally, it was clear that virtually all sites in the medial half of the dorsal neostriatum failed to enhance attraction to Pavlovian cues. Sites in the DMS (i.e. within 2.5 mm of midline) were nearly unanimously silent in enhancing either sign-tracking or goal-tracking, sharply contrasting to the efficacy of sites in the DLS in enhancing Pavlovian incentive salience.
Rigid habit or flexible motivation?
Did DLS DAMGO enhance the prepotent CS approach as a ritualized or automatic habit of pre-programmed movements? Or by making the cue into a stronger motivational magnet, which was attractive independent of any habitual rituals used to approach? S-R Smith & Graybiel, 2013) . Consequently, habits can famously perseverate even when guiding stimuli are suddenly moved (Carr & Watson, 1908) . DLS in particular has been implicated in the control of such stereotyped movement sequences, both for instinctive ritualized action patterns and for learned habits, DLS neurons change firing and alter stimulus processing over the course of habit learning as movement patterns become more automatic (Graybiel, 2008; Kalueff et al., 2016; Smith & Graybiel, 2016) . Sign-tracking was focused on here, because it was more feasible to move the CS+Lever to a different slot located on an opposite wall than to move the sucrose dish for goal-trackers. Similar to Carr & Watson (1908) , the current study predicted that if DLS opioid stimulation potentiates an automatic stimulus-response habit or motor ritual, DLS DAMGO microinjection would make rats persist in repeating their pre-established motor ritual, and continue to approach the original location. Conversely, it was predicted that if DLS opioid stimulation makes sign-trackers motivationally more attracted toward the CS+Lever, then after DAMGO microinjection sign-tracker rats should flexibly abandon their old location and ritual, and follow the lever to a new location, even if the switch required a change in movement pattern.
It was observed that rats did tend to each develop a particular ritualized approach pattern, a potential habit that was shared by virtually all sign-trackers, and was quite evident by the final day of training (Fig. 6A ). This sign-tracking ritual followed a sequence that used predictable movements: (i) before the lever emerged, a rat typically sat within 3 cm of the goal dish (typically, the rat had just obtained a sucrose pellet from the dish on a previous presentation); (ii) when the CS+Lever appeared in the chamber about 5 cm away from the rat, the rat first typically turned 30-90°toward the CS+Lever; (iii) next, the rat took an initial small-stride forelimb step toward the CS+Lever (< 2 cm stride); followed immediately by (iv) a corresponding small hind step pulling up the hind leg toward the shifted forequarters (< 2 cm step); and then (v) repeated alternating series of small #3 forelimb & #4 hindlimb steps until the head was within 1 cm of the CS+Lever) from that lever-proximal position; (vi) the rat merely leaned its head forward without moving the legs to make mouth (lip and tongue) contact with the CS+Lever, often accompanied by a forelimb grasp of the lever; and finally initiated (vii) repetitive consummatory sniffing and nibbling sequences on the metal lever as long as it remained present (8 s duration; Fig. 6A ). Microinjections of either DAMGO or vehicle were made bilaterally in the DLS of sign-trackers (between-subject comparison; randomly assigned) immediately before the location of the CS+Lever was shifted to the opposite side of the cage (a previously empty slot in the opposite wall). The crucial test focused on the first three CS+Lever presentations in the new location after DLS microinjections, when the CS+Lever now emerged on the opposite wall from where it had previously been.
Results showed that rats uniformly abandoned their potentially habitual pattern of approach on the very first presentation of the newly-located CS+Lever after DAMGO (or vehicle) microinjections in the DLS. Instead of returning to the old location after DAMGO microinjection, all sign-trackers went directly to the new location that was in the opposite direction from before, and further away. Opioid stimulation of DLS did not cause rats to perseverate in visits to the old location: instead, rats actually visited their old location fewer times than rats that received vehicle microinjections (DAMGO = 0.68 AE 0.3 visits to old location per session; vehicle = 0.78 AE 0.6; P > 0.05; Fig. 6B and E) . Similarly, if anything, DLS DAMGO rats tended to reach the new cue location slightly faster than rats that received vehicle microinjections (though this was only a trend, and speed did not quite reach statistical significance; DAMGO latency = 4.2 s; vehicle latency = 5.13 s, P > 0.05; Fig. 6B and D) .
Further, in terms of movement microstructure, rats changed their ritualized movement pattern after DLS DAMGO. In the new movement pattern, rats typically: (i) turned 90-180°in the opposite direction away from their previous direction of turn; (ii) took a longer initial forelimb step than previously (toward the > 5 cm more distant location); (iii) and took a correspondingly longer initial hindlimb step (> 5 cm); and then (iv) repeated steps #2 and #3 several more times until reaching the new location (Fig. 6B) . Finally, once the CS+Lever was reached in its new location after DAMGO in the DLS, rats trended toward emitting more consummatory nibbles on the metal lever than control vehicle rats (vehicle = 2.79 AE 1.2, DAMGO = 3.85 AE 0.96, P > 0.05; Fig. 6B and C) . In short, DAMGO did not cause rats to perseverate to the old location, suggesting it did not strengthen a ritualized motor habit. Instead, they shifted flexibly, abandoning their old movement ritual with greater alacrity, adopting a new and different movement pattern, and directing more ingestive-consummatory actions toward the metal object in its new location -all consistent with the idea that DLS DAMGO had strengthened the CS+Lever as an attractive motivational magnet.
DLS opioid stimulation enhances motivation to earn CS+Lever on the new instrumental task (conditioned reinforcer)
An independent way of assessing whether DLS stimulation enhances 'wanting' is to test for a different feature of incentive salience: instrumental conditioned reinforcement (Robinson & Berridge, 2003) . The current conditioned reinforcement results showed that DAMGO microinjection in the DLS did indeed make sign-trackers 'want' to obtain the CS+Lever cue more, in the sense of working harder on a new nose-poke instrumental task to earn brief presentations of the CS+Lever. Rats that received DAMGO in the DLS worked 150% harder in their very first session on the newly-learned nose-poke task to earn presentations of the Pavlovian CS+Lever, compared with control rats that received vehicle microinjections (38 AE 7.5 vehicle; 57.1 AE 5.54 DAMGO; F 1,19 = 4.6, P = 0.045, gp 2 = 0.195). DLS DAMGO rats poked specifically in the 'active' port hole that earned the CS+Lever, and did not poke in the control inactive hole (inactive pokes F 1,19 = 0, P = 0.992; nose-poke type* drug interaction F 1,38 = 4.229, P = 0.047, gp 2 = 0.1; Fig. 7) . By contrast to DLS enhancement of conditioned reinforcement, DAMGO at sites in the DMS failed to make rats perform more nose-pokes to earn CS+Lever presentations compared with vehicle (F 2,6 = 0.675, P = 0.544). DAMGO microinjections in the DMS had no effect on the number of responses for either the active hole or inactive hole (CS+Lever hole: vehicle = 53.87, DAMG O = 56.37, vehicle = 33.12, DAMGO = 25.37; F 1,7 = 0.071, P = 0.789; control hole F 1,7 = 0.905, P = 0.375). This pattern seemed to confirm that DLS, but not DMS, supports opioid enhancement of incentive salience, at least for a Pavlovian CS+ that predicts sucrose reward.
Discussion
The current results suggest that the DLS contributes to amplifying incentive motivation triggered by Pavlovian reward cues, beyond its traditional role as 'motor striatum' chiefly involved in the regulation of movement, habits and sequences. Here, local mu opioid or dopamine stimulation in the DLS selectively magnified the motivational attractiveness of one particular reward-cue for each rat, interacting with its pre-existing sign-tracking vs. goal-tracking individual phenotype. The current results indicate that opioid or dopamine stimulation in the DLS can specifically enhance Pavlovian incentive salience in a focused manner for a single target CS.
Cue enhancements by mu opioid vs. dopamine stimulation in DLS
In virtually all sign-trackers, mu opioid stimulation in DLS via DAMGO microinjection magnified attraction specifically toward their prepotent CS+Lever (or 'sign' predicting reward UCS), producing a faster approach, higher probability of approach and more consummatory sniff-nibble reactions to the metal lever cue once reached. By contrast, in goal-trackers DLS DAMGO instead magnified attraction and consummatory reactions toward their prepotent CS dish (the 'goal') . Thus, in both goal-trackers and sign-trackers, DAMGO enhanced attraction to the individual's prepotent Pavlovian cue, and simultaneously pulled attraction away from the other competing cue. Also, for both goal-trackers and sign-trackers, the temporal trigger for enhanced cue attraction was always presentation of the CS+Lever. Even for goal-trackers, the CS+Lever triggered phasic increases in attraction to the CS dish , even though the dish always remained physically present while the lever was absent.
Dopamine stimulation in the DLS by amphetamine microinjection also enhanced attraction toward one particular cue, but with a stronger goal-tracking bias towards the CS dish in a larger population of rats. This bias was strong enough to actually switch the maximally attractive target for some sign-trackers, from lever to dish, as well as enhance dish attraction for all goal-trackers. That is, any signtracker individuals that were not entirely exclusive in CS+Lever attraction under vehicle (meaning that they defected to the dish before the CS+Lever was retracted on vehicle test day) switched targets when tested under DLS amphetamine. Only exclusive signtrackers, which never defected to the dish while CS+Lever was present on vehicle trials, instead showed enhancement of prepotent sign-tracking responses toward the lever after amphetamine microinjection in DLS (i.e. similar to the effect in all sign-trackers of DLS DAMGO microinjection). Once again, regardless of which cue was the target, the dopamine-induced enhancement of attraction was always temporally bound to moments when the triggering CS+Lever was physically present, and never occurred during intervening nolever periods (even when the CS dish was target, which remained always available). Finally, for both dopamine and opioid stimulation of DLS, enhanced CS attraction was accompanied by an increase in consummatory nibbles and sniffs directed toward the metal target cue once it was reached.
Motivational nature of sign-tracking vs. goal-tracking
Sign-tracking has been suggested specifically to reflect incentive salience attributed to the predictive CS+Lever (Robinson et al., 2014b) . Goal-tracking, by contrast, could in principle be mediated by other psychological processes, for example: (i) cognitive act-outcome expectations that sucrose would be obtained in the dish; and (ii) automatic stimulus-response habits of approach movements that were previously elicited during CS-UCS pairings. Accordingly, Robinson, Flagel and colleagues have reported that normal signtracking is more closely associated with endogenous dopamine responses in the nucleus accumbens than normal goal-tracking (Flagel et al., 2011; Robinson et al., 2014b) . They suggest that goal-tracking is instead mediated predominantly by the alternative psychological mechanisms in normal rats. It may be true that goal-tracking under normal conditions is less purely mediated by incentive salience than sign-tracking. However, states of mesocorticolimbic stimulation, induced by DAMGO microinjections in structures such as the central amygdala or induced after some cases of amphetamine sensitization, can enhance goaltracking as a motivated response by amplifying incentive salience, which becomes targeted on the CS dish (Mahler & Berridge, 2009; Simon et al., 2009; Holden & Peoples, 2010; Robinson et al., 2015a) . In those stimulated mesocorticolimbic states, the CS dish can become a more 'wanted' motivational magnet for goal-trackers, similar to the CS+Lever for signtrackers. In both cases, the trigger for the phasic pulse of higher incentive salience remains presentation of the CS+Lever.
Even though the CS dish is less predictively correlated than the CS+Lever to sucrose, a rat typically experiences CS dish as a contiguous cue immediately prior to sugar consumption. Early animal learning studies indicated that contiguous CSs may also often elicit motivated responses, similar to predictive CSs (Zener, 1937; Rescorla & Cunningham, 1979; Delamater & Holland, 2008) . Pavlov emphasized the CS-UCS closeness factor in his 'law of temporal contiguity', and subsequently both contiguity and correlation have been viewed as important in Pavlovian learning, each emphasized to varying degrees by different investigators (Pavlov, 1927; Rescorla, 1972; Mackintosh, 1974; LoLordo, 1979; Gallistel & Balsam, 2014) . The idea that goal-tracker individuals can become highly motivated under at least some conditions also may be compatible with the recent report that goal-trackers can actually show higher relapse in cocaine seeking than sign-trackers when triggered by contextual cues (rather than by a discrete Pavlovian CS; Saunders et al., 2014) .
The current results indicate that opioid/dopamine stimulation in DLS can enhance intensification of motivated goal-tracking as well as sign-tracking, similarly to some mesocorticolimbic stimulations. In particular, the pattern of enhanced prepotent cue attraction observed after DAMGO microinjections in DLS was nearly identical to that previously reported for DAMGO microinjections in the central nucleus of the amygdala (Mahler & Berridge, 2009; . That similarity raises the possibility that DAMGO microinjection in the DLS and central amygdala might activate different nodes of the same functional circuit, resulting in similarly enhanced Pavlovian motivation. This possibility also seems consistent with related evidence for functional interaction between the DLS and central amygdala, from studies of surprise-induced attention and conditioned orienting (Han et al., 1997; Esber et al., 2015) .
Phasic nature of DLS enhancements of Pavlovian attraction: CS+Lever as trigger
Why was the enhancement of incentive salience tied, phasically, to presentations of the CS+Lever, when DAMGO or amphetamine activation of DLS would have remained relatively constant throughout the entire session? For incentive salience enhancements, the pharmacological DLS stimulation would have acted as a physiological state (kappa) (Zhang et al., 2009) , similar to an appetite or satiety state (Robinson & Berridge, 2013) . Even though a pharmacological/physiological kappa state may last many minutes or hours, its most potent effects on motivated behaviours are much shorter and cuelinked, because incentive salience generation involves an interaction of such neurobiological kappa states with phasic encounters of Pavlovian reward cues. Thus, DAMGO or amphetamine microinjection in the DLS specifically and multiplicatively amplified the CS+Lever cue's ability to trigger a phasic surge in incentive motivation. The temporal trigger remained the same regardless of whether the amplified incentive salience focused on the CS+ Lever or CS dish as target. By contrast, when the lever was retracted, the multiplicative interaction had no triggering CS+Lever association to amplify, which is why DLS stimulation alone would not directly drive an increase in motivated approach (not even to dish) when the lever was missing (Mahler & Berridge, 2009; .
DLS stimulation: stronger motor habit or amplified incentive salience?
DLS is often posited to contribute to stimulus-response habits (Packard & Knowlton, 2002; Aldridge et al., 2004; Balleine et al., 2007; Tang et al., 2007; Yin, 2010; Bornstein & Daw, 2011; Everitt & Robbins, 2013; Smith & Graybiel, 2013) . So can DLS-induced strengthening of a habit explain the behaviours observed here? An answer to this question is made more difficult by the observation that there actually is no widespread agreement in neuroscience on the defining positive features of a habit. Indeed, habits are often described more in terms of features lacked (i.e. not goal-directed; not flexible; not motivated; etc.) rather than in terms of positive features that allow the habit to be recognized as such.
Automaticity was a useful defining feature of habit in classical and behaviourist psychology of a century ago (James, 1890; Carr & Watson, 1908; Guthrie, 1935) . The defining feature of a habit was its automatic stereotypy of a sequential pattern: a ritual that could be performed without attention, indeed being especially liable to surface when attention was distracted, and which always appeared in the same, invariable, behavioural sequence. Automaticity and sequential stereotypy is also emphasized by some modern neuroscientists who study DLS mediation of movement and action rituals (Graybiel, 2008; Kalueff et al., 2016) . For example, Graybiel (2008) suggested 'habits are sequential, repetitive, motor, or cognitive behaviours elicited by external or internal triggers that, once released, can go to completion without constant conscious oversight' (p. 361).
Automaticity and ritualized sequential stereotypy was the particular feature exploited by Carr & Watson (1908) to expose welllearned habits in their classic 'kerplunk!' experiment, and was also the feature used by the current moved-cue experiment. In the current study, after opioid DLS stimulation, sign-trackers did not rigidly perseverate in their habitual movement sequence to the old location when the CS+Lever was suddenly moved, but instead switched immediately to the new location and adopted a new movement pattern to go there. Further, amphetamine microinjection in the DLS actually switched non-exclusive sign-trackers from their characteristic sign-tracking response to instead mostly goal-tracking while the lever was present: altering their most preferred target stimulus as well as their previous movement sequence.
Alternatively, a habit may also be motivated -in which case it is no longer merely a habit. Adding motivational compulsion in the form of amplified incentive salience of attractive stimuli could make their approach more intense and difficult to control. This may be similar to the proposal by Everitt, Robbins and colleagues that DLS can endow addictive habits with a compulsive 'must do!' feature to persist in the face of punishment (Belin et al., 2009; Everitt & Robbins, 2016) . It is suggested that compulsion necessarily adds a motivational process: only motivation can give a 'must!' feature to a habit that otherwise would be merely 'done' automatically as a routine. The authors' suggestion is similar to a distinction made between mere automatic rituals vs. compulsively motivated obsessions in obsessive-compulsive disorder (Boyer & Lienard, 2008) .
The current results may be the first to demonstrate that DLS circuitry is actually capable of intensifying motivated attraction to a learned target stimulus, with several signature features of incentive salience. First, the increased attraction was flexible, easily adjusting when the target moved. Next, DAMGO and amphetamine in DLS also amplified the targeted cue's ability to elicit ingestive-type consummatory actions, so the rat more intensely sniffed and nibbled the cue as though the metal CS object was the sucrose UCS itself. Further, the target for maximal incentive salience flexibly switched to a different stimulus in the case of amphetamine microinjection in DLS that made non-exclusive sign-trackers become stronger goal-trackers. A switch from lever to dish as target is more evidence against the habit explanation, demonstrating flexibility in attractive stimulus as well as in motor approach. Finally, DLS-enhancement of CS 'wanting' was evident even in the absence of any physical target stimulus: DAMGO microinjection in the DLS of sign-trackers enhanced instrumental conditioned reinforcement, magnifying effort on a newly-learned response to earn brief presentations of their absent CS+Lever. Although conditioned reinforcement can be alternatively explained by other processes (e.g. response 'stamping in' or related reinforcement processes), being more willing to work to gain a 'wanted' cue is another feature predicted by enhanced incentive salience that involves no possible habit of stimulus-response approach (Robinson & Berridge, 1993) . Overall, this pattern of observations was interpreted to indicate that DLS opioid/dopamine stimulation, interacting with individualized phenotypes, made a targeted CS become more motivationally 'wanted', more attractive yet flexibly approached, more avidly nibbled as though it were sucrose when reached, and more highly sought when missing.
Opioid vs. dopamine roles in DLS
Opioid and dopamine stimulations in DLS enhanced CS incentive salience in ways that were related, but not identical. To understand the difference between motivation effects of opioid vs. dopamine stimulation in DLS, it may be relevant to note that mu opioid receptors are expressed postsynaptically on medium spiny neurons primarily in patches or striosomes in DLS and other neostriatum regions, and have been suggested to tune neuronal responses to dopamine and other neuromodulators (Pert et al., 1976; Herkenham & Pert, 1980; Gerfen, 1984; Banghart et al., 2015) , whereas dopamine receptors occur on neurons in the matrix compartment as well as in patches/striosomes (Besson et al., 1988; Graybiel, 1990; Crittenden & Graybiel, 2011) . Patch neurons in the DLS also receive inputs primarily from limbic regions of the prefrontal cortex, including prelimbic and anterior cingulate regions, whereas matrix neurons receive inputs predominantly from the motor cortex and somatosensory cortex (Ragsdale & Graybiel, 1990; Eblen & Graybiel, 1995; Kincaid & Wilson, 1996; Levesque & Parent, 1998; Haber et al., 2006) . Regarding output targets, patch neurons project more directly to midbrain dopamine neurons in substantia nigra pars compacta, whereas matrix neurons project to the pars reticulata (Crittenden & Graybiel, 2011; Fujiyama et al., 2011) . Therefore, one possibility is that mu opioid receptor stimulation by DAMGO microinjection in DLS altered neuronal function in patches more particularly than in matrix, and in turn preferentially modulated direct nigrostriatal projections. By contrast, endogenous local dopamine release from amphetamine microinjections in DLS would more equally modulate patch and matrix neurons together, as well as impact presynaptic terminals of ascending dopamine neurons and of corticolimbic glutamate neurons that also express dopamine receptors (Gerfen, 1984; Packard & Knowlton, 2002; Crittenden & Graybiel, 2011) . Finally, the current DLS amphetamine enhancement of approach biased toward goal-tracking (at least, in all but exclusive sign-trackers) seems conceptually similar to effects reported for systemic amphetamine administration or for some cases of amphetamine-induced sensitization that also enhanced goal-tracking (Simon et al., 2009; Holden & Peoples, 2010) , potentially indicating a shared dopamine bias toward goal-tracking (although see also Doremus-Fitzwater & Spear, 2011; Robinson et al., 2015a for sign-tracking enhancements by dopamine or by amphetamine-induced sensitization).
Anatomical localization and neurochemical mechanisms of motivation amplification
Neuroanatomically, only sites located in the lateral half of the most dorsal 25% of the neostriatum supported opioid/dopamine enhancements of cue attraction here (i.e. sites in DLS). By contrast, all sites in the medial half of the dorsal neostriatum failed to enhance cue attraction (i.e. sites in DMS). Within DLS, both anterior and posterior sites appeared equally effective at enhancing Pavlovian incentive salience for sign-trackers and goal-trackers. The current finding that DMS sites failed to enhance Pavlovian cue attraction to a target CS contrasts with the previous report that DAMGO microinjections in the anterior DMS powerfully increased intake of palatable food as UCS (anterior DMS surges of endogenous enkephalin also were triggered by eating a palatable sweet food UCS in that study; . Here, DLS opioid stimulation did not promote food UCS consumption. Thus, DLS enhancements of incentive salience of a Pavlovian CS seem distinct from DMS enhancement of motivation to consume a food UCS. This double dissociation between DLS enhancement of cue-triggered incentive motivation directed towards learned Pavlovian CSs, vs. anterior DMS enhancement of UCS-targeted motivation directed towards unconditioned foods may also be consistent with reports that DMS lesions impair goal-directed behaviour guided by cognitive memories of food UCS value, operating in act-outcome representations to guide actions (Yin et al., 2005) . Conversely, a DLS role in Pavlovian motivation is consistent with the disruption of cue-triggered 'wanting' to obtain reward after DLS lesions in PIT tests (Corbit & Janak, 2007) . DLS lesions also disrupt other cue-triggered reactions, some of which might involve motivational components, as well as disrupting other complex sequences of instinctive action (Yin et al., 2006; Belin & Everitt, 2008; Murray et al., 2012; Lucantonio et al., 2014; Kalueff et al., 2016) .
Conclusion: DLS modulates cue-triggered incentive motivation
Within the DLS, local mu opioid or dopamine stimulation specifically enhanced attraction toward one particular Pavlovian reward cue in an individually tailored fashion. This is consistent with a 'winner-take-all' enhancement of that cue's incentive salience, making it specifically more highly 'wanted' and attractive, at the expense of the competing reward cue. A motivational role for DLS in enhancing Pavlovian incentive salience seems consistent with other reports of motivation effects caused by dorsal neostriatum manipulations, including optogenetic self-stimulation of dorsal neostriatal D1-expressing neurons (Kravitz et al., 2012) and rescue of eating behaviour in aphagic dopamine-deficient mice by dorsal neostriatal dopamine replacement (Palmiter, 2008) . A role for DLS in cue-triggered incentive motivation is also consistent with many reports of dorsal neostriatal activity increases evoked by reward cues in both animals and humans (Ito et al., 2002; Volkow et al., 2002; Stice et al., 2008; Nummenmaa et al., 2012; Jastreboff et al., 2013; Li et al., 2015) . Applied to addiction, an incentive salience role for DLS circuitry in making a particular reward CS+ more attractive would increase the danger of cue-triggered addictive relapse, especially when craving, pursuit and consumption were pulled toward a targeted CS as a suddenly more powerful motivational magnet.
